Baseline characteristics and antiretroviral drug regimens of study participants upon LSM examination (n = 93).

NOTE. Data are expressed as mean ± SD, number (percent), or median (interquartile range). LSM, liver stiffness measurement; cART, combined antiretroviral treatment; AIDS, Adult immunodeficiency syndrome; CDC, Centers for Disease Control and Prevention; kPa, kilopascal; INR, international normalized ratio; NRTIs, nucleoside analogue reverse transcriptase inhibitors; NNRTIs, non-nucleoside analogue reverse transcriptase inhibitors; PIs, protease inhibitors. aA change to co-formulated drugs with the same components was not considered to be a change in antiretroviral drugs.